Terms: = Sarcomas AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
421 results:
1. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
2. Cascade Co
Wang L; Wang T; Zhuo Y; Xu S; Liu H; Jiang X; Lu Z; Wang X; Rao H; Wu D; Wang Y; Feng B; Sun M
J Colloid Interface Sci; 2024 May; 662():962-975. PubMed ID: 38382379
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer effects of rutin from Fagopyrum tataricum (tartary buckwheat) against osteosarcoma cell line.
Soosai D; Ramalingam R; Perumal E; Veeramani K; Pancras C; Almutairi MH; Savarimuthu LAR; Veeramuthu D; Antony S
Mol Biol Rep; 2024 Feb; 51(1):312. PubMed ID: 38374412
[TBL] [Abstract] [Full Text] [Related]
4. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
5. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
Morales AE; Gumenick R; Genovese CM; Jang YY; Ouedraogo A; Ibáñez de Garayo M; Pannellini T; Patel S; Bott ME; Alvarez J; Mun SS; Totonchy J; Gautam A; Delgado de la Mora J; Chang S; Wirth D; Horenstein M; Dao T; Scheinberg DA; Rubinstein PG; Semeere A; Martin J; Godfrey CC; Moser CB; Matining RM; Campbell TB; Borok MZ; Krown SE; Cesarman E
PLoS Pathog; 2024 Jan; 20(1):e1011881. PubMed ID: 38190392
[TBL] [Abstract] [Full Text] [Related]
6. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
8. Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology.
Chen L; Zhou Y; Weng Z; Liu S; Li T; Wang Y; Yang Y; Liu H; Huang W
Aging (Albany NY); 2023 Oct; 15(20):11489-11507. PubMed ID: 37870753
[TBL] [Abstract] [Full Text] [Related]
9. Multiproperty Polyethylenimine-Caged Platinum Nanoclusters Promote Apoptosis of Osteosarcoma Cells via Regulating the BAX-bcl-2/Caspase-3/PARP Axis.
Wang J; Zhang M; Huang X; Yue H
Mol Pharm; 2023 Nov; 20(11):5607-5615. PubMed ID: 37831437
[TBL] [Abstract] [Full Text] [Related]
10. KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.
Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
[TBL] [Abstract] [Full Text] [Related]
11. BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours.
Yu Q; Fu W; Fu Y; Ye W; Yan H; Yu Z; Li R; Cai Y; Chen Y; Wang L; Wei X; Chen Y; Zhang Y; Ying H; Tang F; Dai F; Han W
Mol Cancer; 2023 Aug; 22(1):143. PubMed ID: 37649051
[TBL] [Abstract] [Full Text] [Related]
12. Histological response to radiotherapy is an early event in myxoid liposarcoma.
Lam SW; Silva TM; Traast-Kooistra J; Bruijn IB; van den Akker B; Bakker PAC; Lansu J; Haas RLM; Bovée JVMG
Virchows Arch; 2023 Oct; 483(4):487-495. PubMed ID: 37572156
[TBL] [Abstract] [Full Text] [Related]
13. Network pharmacology-based research on the effect of angelicin on osteosarcoma and the underlying mechanism.
Zhang Y; Wei J; Kong L; Song M; Zhang Y; Xiao X; Cao H; Li Z; Yang N; Jin Y
Aging (Albany NY); 2023 Jun; 15(11):5125-5143. PubMed ID: 37301545
[TBL] [Abstract] [Full Text] [Related]
14. Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.
Moore LN; Holmes DL; Sharma A; Landazuri Vinueza J; Lagunoff M
PLoS Pathog; 2023 May; 19(5):e1011385. PubMed ID: 37163552
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-215-5p promotes proliferation, invasion, and inhibits apoptosis in liposarcoma cells by targeting MDM2.
Song Z; Bai J; Jiang R; Wu J; Yang W
Cancer Med; 2023 Jun; 12(12):13455-13470. PubMed ID: 37132262
[TBL] [Abstract] [Full Text] [Related]
16. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
Fu L; Zhang Z; Chen Z; Fu J; Hong P; Feng W
Curr Treat Options Oncol; 2023 Apr; 24(4):338-352. PubMed ID: 36877373
[TBL] [Abstract] [Full Text] [Related]
17. Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
Zhen H; Tian J; Li G; Zhao P; Zhang Y; Che J; Cao B
BMC Cancer; 2023 Mar; 23(1):207. PubMed ID: 36870981
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
[TBL] [Abstract] [Full Text] [Related]
19. Relaxin inhibits
Xu J; Wan S; Chen W; Zhang Y; Ji Z
Acta Pharm; 2022 Dec; 72(4):575-585. PubMed ID: 36651368
[No Abstract] [Full Text] [Related]
20. Low bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
Pascual-Pasto G; Resa-Pares C; Castillo-Ecija H; Aschero R; Baulenas-Farres M; Vila-Ubach M; Burgueño V; Balaguer-Lluna L; Cuadrado-Vilanova M; Olaciregui NG; Martinez-Velasco N; Perez-Jaume S; de Alava E; Tirado OM; Lavarino C; Mora J; Carcaboso AM
Biochem Pharmacol; 2023 Feb; 208():115408. PubMed ID: 36603685
[TBL] [Abstract] [Full Text] [Related]
[Next]
